Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for epithelioid inflammatory myofibroblastic sarcoma has been reported in the published literature.
No clinical trials have been registered for epithelioid inflammatory myofibroblastic sarcoma.
20 publications have been identified in PubMed for epithelioid inflammatory myofibroblastic sarcoma. Research spans Case Report / Case Series (80%), Review / Meta-Analysis (10%), and Diagnostic / Biomarker (5%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 16 | 80% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 9:41 AM UTC
Research summaries
2 |
10% |
Testing and diagnosis research | 1 | 5% |
Laboratory research | 1 | 5% |
Terzioglu HG (2026). [PMID: 42175623](https://pubmed.ncbi.nlm.nih.gov/42175623/). *Diagn Cytopathol*. [Case Report / Case Series]
Bian HX (2026). [PMID: 41956758](https://pubmed.ncbi.nlm.nih.gov/41956758/). *Zhonghua Bing Li Xue Za Zhi*. [Case Report / Case Series]
Lei T (2026). [PMID: 42252217](https://pubmed.ncbi.nlm.nih.gov/42252217/). *Zhonghua Bing Li Xue Za Zhi*. [Basic Science / Preclinical]
Maharjan D (2025). [PMID: 40386890](https://pubmed.ncbi.nlm.nih.gov/40386890/). *Genes, chromosomes & cancer*. [Case Report / Case Series]
Zeng H (2025). [PMID: 40353528](https://pubmed.ncbi.nlm.nih.gov/40353528/). *Anti-cancer drugs*. [Case Report / Case Series]
Zhang H (2025). [PMID: 41179654](https://pubmed.ncbi.nlm.nih.gov/41179654/). *Frontiers in oncology*. [Case Report / Case Series]
Shi C (2025). [PMID: 40224190](https://pubmed.ncbi.nlm.nih.gov/40224190/). *Frontiers in oncology*. [Case Report / Case Series]
Choi JH (2025). [PMID: 40282503](https://pubmed.ncbi.nlm.nih.gov/40282503/). *Cancers*. [Review / Meta-Analysis]
Chaudhry SS (2025). [PMID: 41245950](https://pubmed.ncbi.nlm.nih.gov/41245950/). *Rare tumors*. [Case Report / Case Series]
Zhao Y (2025). [PMID: 41777067](https://pubmed.ncbi.nlm.nih.gov/41777067/). *Zhongguo fei ai za zhi = Chinese journal of lung cancer*. [Case Report / Case Series]